Copenhagen Center for Glycomics, Departments of Cellular and Molecular Medicine and School of Dentistry, Faculty of Health Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.
Mol Cell Proteomics. 2013 Apr;12(4):932-44. doi: 10.1074/mcp.O112.021972. Epub 2013 Feb 11.
Characterizing protein GalNAc-type O-glycosylation has long been a major challenge, and as a result, our understanding of this glycoproteome is particularly poor. Recently, we presented a novel strategy for high throughput identification of O-GalNAc glycosites using zinc finger nuclease gene-engineered "SimpleCell" lines producing homogeneous truncated O-glycosylation. Total lysates of cells were trypsinized and subjected to lectin affinity chromatography enrichment, followed by identification of GalNAc O-glycopeptides by nLC-MS/MS, with electron transfer dissociation employed to specify sites of O-glycosylation. Here, we demonstrate a substantial improvement in the SimpleCell strategy by including an additional stage of lectin affinity chromatography on secreted glycoproteins from culture media (secretome) and by incorporating pre-fractionation of affinity-enriched glycopeptides via IEF before nLC-MS/MS. We applied these improvements to three human SimpleCells studied previously, and each yielded a substantial increase in the number of O-glycoproteins and O-glycosites identified. We found that analysis of the secretome was an important independent factor for increasing identifications, suggesting that further substantial improvements can also be sought through analysis of subcellular organelle fractions. In addition, we uncovered a substantial nonoverlapping set of O-glycoproteins and O-glycosites using an alternative protease digestion (chymotrypsin). In total, the improvements led to identification of 259 glycoproteins, of which 152 (59%) were novel compared with our previous strategy using the same three cell lines. With respect to individual glycosites, we identified a total of 856 sites, of which 508 (59%) were novel compared with our previous strategy; this includes four new identifications of O-GalNAc attached to tyrosine. Furthermore, we uncovered ≈ 220 O-glycosites wherein the peptides were clearly identified, but the glycosites could not be unambiguously assigned to specific positions. The improved strategy should greatly facilitate high throughput characterization of the human GalNAc-type O-glycoproteome as well as be applicable to analysis of other O-glycoproteomes.
鉴定蛋白质 GalNAc 型 O-糖基化一直是一个主要挑战,因此,我们对糖蛋白组的了解特别有限。最近,我们提出了一种使用锌指核酸酶基因工程化的“SimpleCell”系产生同质截断 O-糖基化来高通量鉴定 O-GalNAc 糖基化位点的新策略。细胞的总裂解物用胰蛋白酶消化,并进行凝集素亲和层析富集,然后通过 nLC-MS/MS 鉴定 GalNAc O-糖肽,使用电子转移解离来指定 O-糖基化位点。在这里,我们通过在培养基(分泌组)中的分泌糖蛋白上进行凝集素亲和层析的额外阶段,以及在 nLC-MS/MS 之前通过 IEF 对亲和富集的糖肽进行预分级,对 SimpleCell 策略进行了实质性改进。我们将这些改进应用于之前研究过的三个人类 SimpleCells,每个细胞都大大增加了鉴定的 O-糖蛋白和 O-糖基化位点的数量。我们发现,分析分泌组是增加鉴定数量的一个重要独立因素,这表明还可以通过分析亚细胞器部分来寻求进一步的实质性改进。此外,我们使用替代蛋白酶(糜蛋白酶)消化发现了大量非重叠的 O-糖蛋白和 O-糖基化位点。总的来说,这些改进导致鉴定出 259 种糖蛋白,其中 152 种(59%)与我们之前使用相同的三个细胞系的策略相比是新的。就个别糖基化位点而言,我们总共鉴定出 856 个位点,其中 508 个(59%)与我们之前的策略相比是新的;这包括四个新鉴定的酪氨酸上的 O-GalNAc 连接。此外,我们还发现了大约 220 个 O-糖基化位点,其中肽明显被鉴定出来,但糖基化位点不能明确分配到特定位置。改进的策略应该极大地促进高通量鉴定人类 GalNAc 型 O-糖蛋白组,并且适用于其他 O-糖蛋白组的分析。